EGF and neoplasm: By influencing the tumor microenvironment and the immune system, blocking the expression of COX-2 and the proto-oncogene c-FOS and interfering with the EGF/EGFR pathway, they are able to reduce inflammation, inhibit tumor cell growth, induce apoptosis, and cause autophagy.